StratDeckEarly access
Genus
GNS.LHealthcare · Biotechnology · UK2316.00GBp-1.86%
StratDeckGenus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
Price · Past year
Loading chart…
Checks
- Fail: Price trending down The figures
- Fail: Sales growing slower than its peers The figures
- Pass: More profitable than similar companies The figures
- Pass: Analysts rate it a strong buy The figures
- Pass: Cheaper than similar companies The figures
- Not known: Last quarter's profit forecast not available
Share
Keep researching
Where next from GNS.L
Other stocks you may like
Fundamentals
Yahoo FinanceShowHide
Market cap2.02B
P/E5.4×
Forward P/E19.8×
Price / book2.00
Dividend yield1.42%
Revenue YoY-4.10%
EPS YoY+1341.70%
Net margin43.4%
Return on equity45.9%
Beta0.50
52-week range1943.00–3220.0029/100
Worst fall in a year-38.0%
ADV (USD)7.02M
10d avg volume243K
What's happening?
GNS.L is beating Healthcare this month The figures
- 1D
- -1.86%
- 7D
- +1.58%
- 1M
- +7.72%
- 3M
- +8.73%
- 6M
- -12.41%
- YTD
- -10.75%
What is the market expecting?
StratDeckCheaper than similar companies, and analysts expect the price to rise The figures
AnalystsStrong buy13
Value score vs Healthcare peers
57- Fwd P/E19.833
- P/B2.082
- Yield1.4%37
- P/E5.4100
- Rev growth-4.1%6
Is the business delivering?
Sales are shrinking, and profit per share is up The figures
No reported quarters on file for this stock.
How does it compare?
Nearest in Healthcare on valueStratDeckGNS.L is better value than most Healthcare stocks The figures
What happens next?
Reports next on 25 Feb, in 131 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.